Fate reports FT1050 Phase 1b preliminary data, receives ODD
FT1050 is a small, SCM-designed molecule which enhances hematopoietic stem cell support during the normal course of a stem cell transplant in patients suffering from hematologic malignancies, such
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.